Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Brian Slomovitz, MD, regarding the long term follow-up data on PARP inhibitors in ovarian cancer

Dr. Slomovitz, Professor of Obstetrics & Gynecology, Florida International University, Gynecologic Oncologist, Broward Health, considers the implications of the long term follow-up data on PARP inhibitors in ovarian cancer

Tags: Ovarian

Published: 17 November 2020

Recent Videos

video

Case Study: Advanced Colorectal Cancer in a 56-year-old Female

Daniel Ahn, DO, MS, Assistant Professor of Medicine, Mayo Clinic, Arizona, discusses a case of advanced colorectal cancer in a ...

video

Case Study: Second-Line Treatment of Colorectal Cancer in a 49-year-old Male

Sameh Mikhail, MD, Medical Oncologist, The Zangmeister Cancer Center, and Tanios Bekaii-Saab, MD, FACP, Consultant, Division of Hematology/Oncology, Department of ...

video

Case Study: Metastatic Colorectal Cancer in a 20-year-old Female

Namrata Vijayvergia, MD, Assistant Chief, Gastrointestinal Medical Oncology, Fox Chase Cancer Center, discusses the treatment of metastatic colorectal cancer in ...

video

Brian Slomovitz, MD, regarding the long term follow-up data on PARP inhibitors in ovarian cancer

Dr. Slomovitz, Professor of Obstetrics & Gynecology, Florida International University, Gynecologic Oncologist, Broward Health, considers the implications of the long ...

video

Brian Slomovitz, MD, elaborates on the role of immunotherapy in ovarian cancer

Dr. Slomovitz, Professor of Obstetrics & Gynecology, Florida International University, Gynecologic Oncologist, Broward Health, discusses the role of immunotherapy in ...

video

Brian Slomovitz, MD, offers opinion on the repeat use of PARP inhibitors

Dr. Slomovitz, Professor of Obstetrics & Gynecology, Florida International University, Gynecologic Oncologist, Broward Health, considers whether an ovarian cancer patient ...

video

Brian Slomovitz, MD, on incorporating biomarker-driven therapy in ovarian cancer

Dr. Slomovitz, Professor of Obstetrics & Gynecology, Florida International University, Gynecologic Oncologist, Broward Health, considers whether it is time to ...

video

Eleni Efstathiou, MD, PhD, shares thoughts on the TROPHY-U-01 clinical study presented at ESMO 2020

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, provides perspective on the IPATential150 study in mCRPC

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

video

Eleni Efstathiou, MD, PhD, on whether genetic mutation data impacts the treatment of prostate cancer

Dr. Efstathiou, Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...

Related Videos

video-image

Case Study: Metastatic Colorectal Cancer in a 20-year-old Female

video-image

Case Study: Second-Line Treatment of Colorectal Cancer in a 49-year-old Male

video-image

Case Study: Advanced Colorectal Cancer in a 56-year-old Female

video-image

Brian Slomovitz, MD, on incorporating biomarker-driven therapy in ovarian cancer

video-image

Brian Slomovitz, MD, offers opinion on the repeat use of PARP inhibitors

video-image

Brian Slomovitz, MD, elaborates on the role of immunotherapy in ovarian cancer

video-image

Brian Slomovitz, MD, regarding the long term follow-up data on PARP inhibitors in ovarian cancer

video-image

Eleni Efstathiou, MD, PhD, shares thoughts on the TROPHY-U-01 clinical study presented at ESMO 2020

video-image

Eleni Efstathiou, MD, PhD, discusses the CheckMate 9ER clinical trial presented at ESMO 2020

video-image

Eleni Efstathiou, MD, PhD, offers opinion on whether CheckMate 9ER is practice-changing

video-image

Eleni Efstathiou, MD, PhD, regarding patients more likely to respond to nivolumab + cabozantinib

video-image

Eleni Efstathiou, MD, PhD, on the practice-changing potential of the PROfound study from ESMO 2020

video-image

Eleni Efstathiou, MD, PhD, on whether genetic mutation data impacts the treatment of prostate cancer

video-image

Eleni Efstathiou, MD, PhD, provides perspective on the IPATential150 study in mCRPC

video-image

Ken Kato, MD, PhD, on the role of PD-L1 biomarkers in the treatment of esophageal cancer

video-image

Matthew Galsky, MD, discusses the practice-changing potential of the PROfound study from ESMO 2020

video-image

Arun Azad, MBBS, PhD, FRACP, on the evolving treatment landscape of advanced prostate cancer

video-image

Ken Kato, MD, PhD, shares the design and outcomes of the Keynote-590 trial from ESMO 2020

video-image

Matthew Galsky, MD, on how studies focused on genetic mutations impact prostate cancer treatment

video-image

Matthew Galsky, MD, regarding the TROPHY-U-01 study presented at the 2020 ESMO Virtual Congress